Invesco’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-727,706
| Closed | -$17.2M | – | 3972 |
|
|
2023
Q4 | $17.2M | Sell |
727,706
-214,102
| -23% | -$3.81M | ﹤0.01% | 1485 |
|
|
2023
Q3 | $14M | Buy |
941,808
+19,789
| +2% | +$262K | ﹤0.01% | 1541 |
|
|
2023
Q2 | $10.1M | Sell |
922,019
-32,608
| -3% | -$304K | ﹤0.01% | 1808 |
|
|
2023
Q1 | $8.32M | Buy |
954,627
+815,494
| +586% | +$6.53M | ﹤0.01% | 1937 |
|
|
2022
Q4 | $872K | Sell |
139,133
-29,561
| -18% | -$112K | ﹤0.01% | 2998 |
|
|
2022
Q3 | $590K | Sell |
168,694
-56,560
| -25% | -$203K | ﹤0.01% | 3166 |
|
|
2022
Q2 | $664K | Buy |
225,254
+2,759
| +1% | +$6.59K | ﹤0.01% | 3193 |
|
|
2022
Q1 | $692K | Sell |
222,495
-38,712
| -15% | -$122K | ﹤0.01% | 3246 |
|
|
2021
Q4 | $883K | Buy |
261,207
+2,617
| +1% | +$9.94K | ﹤0.01% | 3134 |
|
|
2021
Q3 | $944K | Buy |
258,590
+20,482
| +9% | +$80.7K | ﹤0.01% | 3128 |
|
|
2021
Q2 | $1.04M | Buy |
238,108
+13,036
| +6% | +$57.8K | ﹤0.01% | 3111 |
|
|
2021
Q1 | $1.02M | Buy |
225,072
+8,665
| +4% | +$46.6K | ﹤0.01% | 3043 |
|
|
2020
Q4 | $1.24M | Sell |
216,407
-1,661,179
| -88% | -$12.6M | ﹤0.01% | 2855 |
|
|
2020
Q3 | $13.6M | Buy |
1,877,586
+1,781,858
| +1,861% | +$9.53M | ﹤0.01% | 1498 |
|
|
2020
Q2 | $334K | Sell |
95,728
-9,886
| -9% | -$28.5K | ﹤0.01% | 3298 |
|
|
2020
Q1 | $156K | Buy |
+105,614
| New | +$177K | ﹤0.01% | 3473 |
|
|
2019
Q4 | – | Sell |
-193,575
| Closed | -$991K | – | 3723 |
|
|
2019
Q3 | $991K | Buy |
193,575
+38,364
| +25% | +$232K | ﹤0.01% | 3002 |
|
|
2019
Q2 | $1.11M | Buy |
+155,211
| New | +$1.76M | ﹤0.01% | 3011 |
|
|
2018
Q4 | – | Sell |
-733,003
| Closed | -$8.12M | – | 3899 |
|
|
2018
Q3 | $8.12M | Buy |
733,003
+380,481
| +108% | +$4.73M | ﹤0.01% | 1849 |
|
|
2018
Q2 | $4.73M | Buy |
352,522
+109,996
| +45% | +$1.38M | ﹤0.01% | 2170 |
|
|
2018
Q1 | $3.15M | Buy |
242,526
+21,866
| +10% | +$272K | ﹤0.01% | 2244 |
|
|
2017
Q4 | $2.03M | Buy |
+220,660
| New | +$1.89M | ﹤0.01% | 2582 |
|